美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
SUPRENZA	202088	001	NDA	PHENTERMINE HYDROCHLORIDE	TABLET, ORALLY DISINTEGRATING;ORAL	15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	No	No	2011/06/13	2011/06/13	CITIUS PHARMS	Discontinued
SUPRENZA	202088	002	NDA	PHENTERMINE HYDROCHLORIDE	TABLET, ORALLY DISINTEGRATING;ORAL	30MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	No	No	2011/06/13	2011/06/13	CITIUS PHARMS	Discontinued
SUPRENZA	202088	003	NDA	PHENTERMINE HYDROCHLORIDE	TABLET, ORALLY DISINTEGRATING;ORAL	37.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	No	No	2011/06/13	2012/03/27	CITIUS PHARMS	Discontinued
SUPRENZA	202088	001	NDA	PHENTERMINE HYDROCHLORIDE	TABLET, ORALLY DISINTEGRATING;ORAL	15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	No	No	2012/03/27	2011/06/13	CITIUS PHARMS	Discontinued
SUPRENZA	202088	002	NDA	PHENTERMINE HYDROCHLORIDE	TABLET, ORALLY DISINTEGRATING;ORAL	30MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	No	No	2012/03/27	2011/06/13	CITIUS PHARMS	Discontinued
SUPRENZA	202088	003	NDA	PHENTERMINE HYDROCHLORIDE	TABLET, ORALLY DISINTEGRATING;ORAL	37.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	No	No	2012/03/27	2012/03/27	CITIUS PHARMS	Discontinued